{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:21:54Z","timestamp":1791573714091,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG034676"],"award-info":[{"award-number":["R01 AG034676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG069052"],"award-info":[{"award-number":["RF1 AG069052"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG006786"],"award-info":[{"award-number":["U01 AG006786"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG062677"],"award-info":[{"award-number":["P30 AG062677"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG069052"],"award-info":[{"award-number":["RF1 AG069052"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG006786"],"award-info":[{"award-number":["U01 AG006786"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG034676"],"award-info":[{"award-number":["R01 AG034676"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG062677"],"award-info":[{"award-number":["P30 AG062677"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tjpad.2025.100224","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:09:46Z","timestamp":1749632986000},"page":"100224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of cardiovascular risk factors on plasma biomarkers in prediction of Alzheimer's and cerebrovascular neuropathology"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9461-5094","authenticated-orcid":false,"given":"Camilo","family":"Bermudez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5990-8206","authenticated-orcid":false,"given":"Jeremy A.","family":"Syrjanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-1252","authenticated-orcid":false,"given":"Nikki H.","family":"Stricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Algeciras-Schimnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-622X","authenticated-orcid":false,"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-066X","authenticated-orcid":false,"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-2294","authenticated-orcid":false,"given":"Christina M.","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4922-3286","authenticated-orcid":false,"given":"Baayla D.C.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aivi T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Ross","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100224_bib0001","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0002","first-page":"1","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2025.100224_bib0003","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23746-0","article-title":"Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations","volume":"12","author":"Cullen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.tjpad.2025.100224_bib0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau-and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0006","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/alz.12466","article-title":"Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities","volume":"18","author":"Syrjanen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0007","article-title":"An accurate fully automated panel of plasma biomarkers for Alzheimer's disease","author":"Palmqvist","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0008","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0009","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.tjpad.2025.100224_bib0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0011","first-page":"1","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease","author":"Mil\u00e0-Alom\u00e0","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2025.100224_bib0012","article-title":"Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia","volume":"12","author":"Shen","year":"2020","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0013","doi-asserted-by":"crossref","first-page":"fcab008","DOI":"10.1093\/braincomms\/fcab008","article-title":"Detection of \u03b2-amyloid positivity in Alzheimer\u2019s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers","volume":"3","author":"Tosun","year":"2021","journal-title":"Brain commun"},{"key":"10.1016\/j.tjpad.2025.100224_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-021-00805-8","article-title":"Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer\u2019s disease pathology and clinical disease progression","volume":"13","author":"Clark","year":"2021","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.tjpad.2025.100224_bib0015","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2025.100224_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-022-00578-0","article-title":"Global neuropathologic severity of Alzheimer\u2019s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels","volume":"17","author":"Murray","year":"2022","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.tjpad.2025.100224_bib0017","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100224_bib0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-023-02594-w","article-title":"Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change","volume":"146","author":"Bermudez","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0019","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100224_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging\u2013Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0022","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0023","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/alz.12647","article-title":"Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: important considerations for clinical trials and practice","volume":"19","author":"O'Bryant","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2022.07.006","article-title":"Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease","volume":"119","author":"Graff-Radford","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tjpad.2025.100224_bib0025","doi-asserted-by":"crossref","first-page":"fcaa132","DOI":"10.1093\/braincomms\/fcaa132","article-title":"Cerebrovascular disease promotes tau pathology in Alzheimer's disease","volume":"2","author":"Laing","year":"2020","journal-title":"Brain Commun"},{"key":"10.1016\/j.tjpad.2025.100224_bib0026","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.tjpad.2025.100224_bib0027","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. USA2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.tjpad.2025.100224_bib0028","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tjpad.2025.100224_bib0029","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/ije\/dys195","article-title":"Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system","volume":"41","author":"St Sauver","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042870","article-title":"Implementing the US Department of Health and Human Services definition of multimorbidity: a comparison between billing codes and medical record review in a population-based sample of persons 40\u201384 years old","volume":"11","author":"St Sauver","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.tjpad.2025.100224_bib0031","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.25071","article-title":"Age, vascular health, and Alzheimer disease biomarkers in an elderly sample","volume":"82","author":"Vemuri","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0032","doi-asserted-by":"crossref","first-page":"fcab076","DOI":"10.1093\/braincomms\/fcab076","article-title":"White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline","volume":"3","author":"Vemuri","year":"2021","journal-title":"Brain commun"},{"key":"10.1016\/j.tjpad.2025.100224_bib0033","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jamaneurol.2017.0244","article-title":"Evaluation of amyloid protective factors and Alzheimer Disease neurodegeneration protective factors in elderly individuals","volume":"74","author":"Vemuri","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0034","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100224_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0036","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of a\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100224_bib0037","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0038","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00401-022-02465-w","article-title":"Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI","volume":"144","author":"Nguyen","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0039","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1212\/WNL.0b013e31824e8e7f","article-title":"Staging and natural history of cerebrovascular pathology in dementia","volume":"78","author":"Deramecourt","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100224_bib0040","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.neurobiolaging.2008.09.011","article-title":"Contribution of vascular pathology to the clinical expression of dementia","volume":"31","author":"Strozyk","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.tjpad.2025.100224_bib0042","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.2147\/JIR.S342097","article-title":"Glial fibrillary acidic protein (GFAP): neuroinflammation biomarker in acute ischemic stroke","volume":"14","author":"Amalia","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.tjpad.2025.100224_bib0043","article-title":"Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology","volume":"14","author":"Shir","year":"2022","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.tjpad.2025.100224_bib0044","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","article-title":"Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3\u00b7 6 million adults in the UK","volume":"6","author":"Bhaskaran","year":"2018","journal-title":"The lancet Diabetes & endocrinology"},{"key":"10.1016\/j.tjpad.2025.100224_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14283\/jpad.2018.41","article-title":"Plasma Abeta42\/40 ratio detects early stages of Alzheimer's Disease and correlates with CSF and neuroimaging biomarkers in the AB255 study","volume":"6","author":"Perez-Grijalba","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100224_bib0046","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ana.26460","article-title":"Tau mediates synergistic influence of vascular risk and abeta on cognitive decline","volume":"92","author":"Yau","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-021-00944-y","article-title":"Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes","volume":"13","author":"Marks","year":"2021","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.tjpad.2025.100224_bib0048","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0049","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero Rodriguez","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2025.100224_bib0050","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/alz.12332","article-title":"Plasma P-tau181 to Abeta42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease","volume":"17","author":"Chong","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100224_bib0051","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:38:39Z","timestamp":1762673919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2274580725001670"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100224","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of cardiovascular risk factors on plasma biomarkers in prediction of Alzheimer's and cerebrovascular neuropathology","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100224"}}